An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Chemistry and Biology

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CHEMBIOL.2006.10.010PMID 17185229PMCID PMC3608209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Asparagine synthetase chemotherapy.

  2006cited by this paper
• Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia

  2006cited by this paper
• The behavior and significance of slow-binding enzyme inhibitors.

  2006cited by this paper
• Statistical analysis of enzyme kinetic data.

  2006cited by this paper
• Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.

  2006cited by this paper
• Using genome-wide transcriptional profiling to elucidate small-molecule mechanism.

  2005cited by this paper
• Expression of Runx1 Isoforms in Sub-Populations of Human Blood and Bone Marrow Cells.

  2005cited by this paper
• A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

  2005cited by this paper
• Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.

  2005cited by this paper
• Advances in chemical genetics.

  2005cited by this paper
• Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• Pegaspargase: a review of clinical studies.

  2003cited by this paper
• Synthesis and characterization of an N-acylsulfonamide inhibitor of human asparagine synthetase.

  2003cited by this paper
• Revisiting the steady state kinetic mechanism of glutamine-dependent asparagine synthetase from Escherichia coli.

  2003cited by this paper
• Tight Binding Inhibitors

  2002cited by this paper
• gamma-Glutamyl thioester intermediate in glutaminase reaction catalyzed by Escherichia coli asparagine synthetase B.

  2002cited by this paper
• Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

  2001cited by this paper
• HPLC Determination of Taurine in Sports Drinks

  2001cited by this paper
• Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase.

  2001cited by this paper
• Channeling of substrates and intermediates in enzyme-catalyzed reactions.

  2001cited by this paper
• Characterization of inhibitors acting at the synthetase site of Escherichia coli asparagine synthetase B.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

  2001cited by this paper
• X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate

  2001cited by this paper
• Dual Role for the Glutamine Phosphoribosylpyrophosphate Amidotransferase Ammonia Channel

  2000cited by this paper
• A Potent Transition-State Analogue Inhibitor of Escherichia coli Asparagine Synthetase A

  1999cited by this paper
• Formation and isolation of a covalent intermediate during the glutaminase reaction of a class II amidotransferase.

  1999cited by this paper
• Three-dimensional structure of Escherichia coli asparagine synthetase B: a short journey from substrate to product.

  1999cited by this paper
• Implicit Solvation Models: Equilibria, Structure, Spectra, and Dynamics.

  1999cited by this paper
• Crystal structure of asparagine synthetase reveals a close evolutionary relationship to class II aminoacyl-tRNA synthetase

  1998cited by this paper
• Enzymes utilizing glutamine as an amide donor.

  1998cited by this paper
• Design, synthesis and evaluation of transition-state analogue inhibitors of Escherichia coli gamma-glutamylcysteine synthetase.

  1998cited by this paper
• Mechanistic issues in asparagine synthetase catalysis.

  1998cited by this paper
• Kinetic mechanism of Escherichia coli asparagine synthetase B.

  1998cited by this paper
• Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells.

  1997cited by this paper
• A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet.

  1996cited by this paper
• Conductor-like Screening Model for Real Solvents: A New Approach to the Quantitative Calculation of Solvation Phenomena

  1995cited by this paper
• Structural model for the reaction mechanism of glutamine synthetase, based on five crystal structures of enzyme-substrate complexes.

  1994cited by this paper
• Arginine 30 and asparagine 74 have functional roles in the glutamine dependent activities of Escherichia coli asparagine synthetase B.

  1994cited by this paper
• Glutamine-dependent nitrogen transfer in Escherichia coli asparagine synthetase B. Searching for the catalytic triad.

  1994cited by this paper
• The amidotransferases.

  1993cited by this paper
• Mechanistic investigations on glucosamine-6-phosphate synthase

  1993cited by this paper
• Management of Children with Acute Lymphoblastic Leukemia by the Dana‐Farber Cancer Institute Protocols: An Update of the Ontario Experience

  1992cited by this paper
• On the use of isovalued surfaces to determine molecule shape and reaction pathways

  1991cited by this paper
• Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.

  1991cited by this paper
• Investigation of the mechanism of phosphinothricin inactivation of Escherichia coli glutamine synthetase using rapid quench kinetic technique.

  1991cited by this paper
• Inhibition of Escherichia coli glutamine synthetase by alpha- and gamma-substituted phosphinothricins.

  1990cited by this paper
• MOPAC: A semiempirical molecular orbital program

  1990cited by this paper
• Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.

  1989cited by this paper
• Optimization of parameters for semiempirical methods I. Method

  1989cited by this paper
• Amino acid analysis by dinitrophenylation and reverse-phase high-pressure liquid chromatography.

  1988cited by this paper
• Effect of the presence of a reversible inhibitor on the time course of slow-binding inhibition.

  1987cited by this paper
• Purification and characterization of beef pancreatic asparagine synthetase.

  1985cited by this paper
• Safety aspects of handling the potent allergen FDNB.

  1980cited by this paper
• Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.

  1979cited by this paper
• Analogs of L-aspartic acid in chemotherapy for cancer.

  1979cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Inhibitors of L-asparagine synthetase, in vitro.

  1976cited by this paper
• A continuous spectrophotometric assay for argininosuccinate synthetase based on pyrophosphate formation.

  1976cited by this paper
• Tight-binding inhibitors-I. Kinetic behavior.

  1975cited by this paper
• l-Glutamate UV-Assay with Gutamate Dehydrogenase and NAD

  1974cited by this paper
• Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia.

  1973cited by this paper
• The amidotransferases.

  1973cited by this paper
• Studies on glutamine synthetase from Escherichia coli. Formation of pyrrolidone carboxylate and inhibition by methionine sulfoximine.

  1973cited by this paper
• Glutamine-dependent asparagine synthetase from leukemia cells. Chloride dependence, mechanism of action, and inhibition.

  1972cited by this paper
• L‐asparaginase therapy in children with advanced leukemia The Southwest cancer chemotherapy study group

  1971cited by this paper
• L-asparaginase and L-asparagine metabolism.

  1970cited by this paper
• The asparagine synthetase of Escherhic coli. I. Biosynthetic role of the enzyme, purification, and characterization of the reaction products.

  1969cited by this paper
• l-asparaginase resistance in human leukemia--asparagine synthetase.

  1969cited by this paper
• Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase.

  1969cited by this paper

• Conformational Remodeling Underlies Activity Loss in Disease-Linked Asparagine Synthetase Variant

  2026cites this paper
• Leveraging Cancer Metabolism to Translate into Effective Therapeutics.

  2025cites this paper
• AIE-Active Cyclometalated Iridium(III) Complex-Based Photocatalyst for Three-Component Sulfoximidotrifluoromethylation of Alkenes.

  2025cites this paper
• Cryo-EM reveals how ASX-173 inhibits human asparagine synthetase to activate the integrated stress response

  2025influential citation
• The ASNS inhibitor ASX-173 potentiates L-asparaginase anticancer activity

  2025cites this paper
• Structural Features Underlying the Mismatch Between Catalytic and Cytostatic Properties in L-Asparaginase from Rhodospirillum rubrum

  2025cites this paper
• Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression

  2023cites this paper
• Silver-mediated Room Temperature Reactions for the Synthesis of N-α-Ketoacyl Sulfoximines and N-α,β-Unsaturated Acyl Sulfoximines

  2023cites this paper
• Arginine-depleting Enzymes, A Potential Treatment Option for Tumors With Arginine Auxotrophy : A Review

  2023cites this paper
• Sirpiglenastat (DRP-104) Induces Anti-tumor Efficacy Through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate & Adaptive Immune Systems.

  2022cites this paper
• Aspartate and Acetate Fuel Gastrointestinal Stromal Tumors Beyond the Warburg Effect

  2022cites this paper
• Modifying dietary amino acids in cancer patients.

  2022cites this paper
• Mechanism and application of nonessential amino acid deprivation associated with tumor therapy

  2022cites this paper
• Structure and Cooperativity in Substrate-Enzyme Interactions: Perspectives on Enzyme Engineering and Inhibitor Design.

  2022cites this paper
• Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

  2021cites this paper
• roduction of Chemotherapeutic Agent L-asparaginase from Gamma-Irradiated Pseudomonas aeruginosa WCHPA075019.

  2021cites this paper
• Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction

  2021influential citation
• Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer.

  2020cites this paper
• Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.

  2020cites this paper
• Improving the Treatment of Acute Lymphoblastic Leukemia

  2020cites this paper
• Clinical, molecular, and biochemical delineation of asparagine synthetase deficiency in Saudi cohort

  2020cites this paper
• Systems Virology and Human Cytomegalovirus: Using High Throughput Approaches to Identify Novel Host-Virus Interactions During Lytic Infection

  2020cites this paper
• ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase.

  2020cites this paper
• Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia

  2020cites this paper
• Drugging cancer metabolism: Expectations vs. reality.

  2019cites this paper
• Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors

  2019cites this paper
• The Diverse Functions of Non-Essential Amino Acids in Cancer

  2019cites this paper
• Asparagine Deprivation Causes a Reversible Inhibition of Human Cytomegalovirus Acute Virus Replication

  2019cites this paper
• High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity

  2019cites this paper
• Title Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase(

  2019cites this paper
• Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response

  2018cites this paper
• Molecular basis of human asparagine synthetase inhibitor specificity

  2018cites this paper
• Therapeutic l-asparaginase: upstream, downstream and beyond

  2017cites this paper
• Glutamine Metabolism in Cancer: Understanding the Heterogeneity.

  2017cites this paper
• Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism

  2017cites this paper
• Drug-induced amino acid deprivation as strategy for cancer therapy

  2017cites this paper
• Metal-Free, Phosphonium Salt-Mediated Sulfoximination of Azine N-Oxides: Approach for the Synthesis of N-Azine Sulfoximines.

  2016cites this paper
• Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase12

  2016cites this paper
• Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines

  2015cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2015cites this paper
• Cell lines and animal model in the analysis of pharmacogenomics markers in childhood acute lymphoblastic leukemia

  2015cites this paper
• Mitochondria as biosynthetic factories for cancer proliferation

  2015cites this paper
• Rhodium-catalyzed direct synthesis of unprotected NH-sulfoximines from sulfoxides.

  2014cites this paper
• Analysis of gene profiles involved in the enhancement of all-trans retinoic acid-induced HL-60 cell differentiation by sesquiterpene lactones identifies asparagine synthetase as a novel target for differentiation-inducing therapy.

  2014cites this paper
• Sulfoximine: Eine vernachlässigte Chance in der medizinischen Chemie

  2013cites this paper
• Sulfoximines: a neglected opportunity in medicinal chemistry.

  2013cites this paper
• Optimized CGenFF force-field parameters for acylphosphate and N-phosphonosulfonimidoyl functional groups

  2013cites this paper
• A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.

  2012cites this paper
• Targeting the ATF4 pathway in cancer therapy

  2012cites this paper
• ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.

  2011cites this paper
• ATF 5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia Running title : Polymorphisms of aspraginase pathway and ALL outcome

  2011cites this paper
• ASNS (asparagine synthetase)

  2011cites this paper
• A conserved glutamate controls the commitment to acyl-adenylate formation in asparagine synthetase.

  2010cites this paper
• Inhibition, characterization, and crystallization of glutamine-dependent asparagine synthetase

  2010cites this paper
• Tunnels and Intermediates in the Glutamine-Dependent Amidotransferases

  2010cites this paper
• A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.

  2009cites this paper
• INTRAMOLECULAR TUNNEL AND REGULATORY MECHANISMS OF ASPARAGINE SYNTHETASE (ASNS)

  2007cites this paper